Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
// Pítia Flores Ledur 1, * , Giovana Ravizzoni Onzi 1, * , Hui Zong 2 and Guido Lenz 1 1 Department of Biophysics and Center of Biotechnology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS–Brazil 2 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA * Authors contributed equally to this work Correspondence to: Hui Zong, email: hz9s@virginia.edu Guido Lenz, email: lenz@ufrgs.br Keywords: culture conditions, culture media, glioblastoma, heterogeneity, drug discovery Received: March 22, 2017 Accepted: August 02, 2017 Published: August 11, 2017 ABSTRACT In cancer research, the use of established cell lines has gradually been replaced by primary cell cultures due to their better representation of in vivo cancer cell behaviors. However, a major challenge with primary culture involves the finding of growth conditions that minimize alterations in the biological state of the cells. To ensure reproducibility and translational potentials for research findings, culture conditions need to be chosen so that the cell population in culture best mimics tumor cells in vivo . Glioblastoma (GBM) is one of the most aggressive and heterogeneous tumor types and the GBM research field would certainly benefit from culture conditions that could maintain the original plethora of phenotype of the cells. Here, we review culture media and supplementation options for GBM cultures, the rationale behind their use, and how much those choices affect drug-screening outcomes. We provide an overview of 120 papers that use primary GBM cultures and discuss the current predominant conditions. We also show important primary research data indicating that "mis-cultured” glioma cells can acquire unnatural drug sensitivity, which would have devastating effects for clinical translations. Finally, we propose the concurrent test of four culture conditions to minimize the loss of cell coverage in culture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 1×
“The habitat of a cancer cell in a solid tumor is a complex niche that includes immune cells, blood vessels, and dynamic pH and oxygen levels, besides the heterogeneity of the tumor population per se [36, 37].”
BackgroundVerhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · cited 2×
“The most up to date classification of glioma in Proneural, Neural, Classical and Mesenchymal subtypes based on molecular signatures [67, 80] might not be representative of individual tumors, but only of a majority of cells within the region of the analyzed biopsy [2].”
BackgroundSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063 · cited 4×
“The most up to date classification of glioma in Proneural, Neural, Classical and Mesenchymal subtypes based on molecular signatures [67, 80] might not be representative of individual tumors, but only of a majority of cells within the region of the analyzed biopsy [2].”
BackgroundInfluentialInfluence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Pollard, S. M., Yoshikawa, K., Clarke, I. D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.014 · Cited by 1,025
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Nature · doi:10.1038/nature07443 · Cited by 767 · cited 1×
“Genetic studies have shown that the introduction of mutations in NF1 and p53 in both embryonic and adult NSCs can lead to gliomagenesis [62, 63], as well as the inactivation of p53 and PTEN in the same cell type [64].”
BackgroundIn Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform
Katt, M. E., Placone, A. L., Wong, A. D., Xu, Z. S., & Searson, P. C. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00012 · Cited by 754 · cited 1×
“Novel in vitro models have been developed, such as 3D cell culture, tissue engineering, biomaterials, microfluidics, allowing us to incorporate different cell types and extracellular matrix components to cultures, as well as to control spatial and temporal introduction of soluble factors [77].”
MethodAlcantara Llaguno, S., Chen, J., Kwon, C.-H., Jackson, E. L., Li, Y., Burns, D. K., Alvarez-Buylla, A., & Parada, L. F. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.006 · Cited by 694 · cited 1×
“Genetic studies have shown that the introduction of mutations in NF1 and p53 in both embryonic and adult NSCs can lead to gliomagenesis [62, 63], as well as the inactivation of p53 and PTEN in the same cell type [64].”
BackgroundCodega, P., Silva-Vargas, V., Paul, A., Maldonado-Soto, A. R., DeLeo, A. M., Pastrana, E., & Doetsch, F. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.039 · Cited by 634
HeLa cells 50 years on: the good, the bad and the ugly
Masters, J. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc775 · Cited by 560
Cited by
Jacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149
From Donor to the Lab: A Fascinating Journey of Primary Cell Lines
Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., Suchorska, W. M., & Trzeciak, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711381 · Cited by 174
Computational estimation of quality and clinical relevance of cancer cell lines
Trastulla, L., Noorbakhsh, J., Vazquez, F., McFarland, J., & Iorio, F. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211017 · Cited by 31
“Historically, glioblastoma (GBM) cell models exhibit a distinct transcriptional state than primary tumours and tend to lose their ability to differentiate when grown in serum-containing media (Lee et al , 2006; Ledur et al , 2017).”
Background
Metadata
- Authors
- Ledur, P. F., Onzi, G. R., Zong, H., & Lenz, G.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-08-11
- Volume
- 8
- Issue
- 40
- Pages
- 69185-69197
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2744344545
- Cited by
- 107
- References
- 15
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries? https://app.cochat.ai/papers/10.18632/oncotarget.20193
- The paper
- Ledur, P. F., Onzi, G. R., Zong, H., & Lenz, G. (2017). Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries? Oncotarget. https://doi.org/10.18632/oncotarget.20193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.